Management of Squamous Cell Cancer of the Oesophagus in a Patient with a Polyglandular Endocrinopathy (APECED) and Achalasia
- First Online:
- Cite this article as:
- Mc Cormack, O., Timlin, M., Mc Gowan, A. et al. J Gastrointest Surg (2012) 16: 1963. doi:10.1007/s11605-012-1879-5
- 144 Downloads
We report a case of a 37-year-old man, with a background of a rare polyglandular autoimmune syndrome and achalasia, who developed an oesophageal tumour. Both autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) or type I polyglandular syndrome and achalasia confer increased risk of development of oesophageal squamous cell carcinoma.
Despite having had multiple endoscopic examinations and dilatations in the recent past, this patient presented with dysphagia, and on endoscopy, he was found to have a mid-oesophageal tumour. A multidisciplinary team approach was vital in his management as careful monitoring of underlying disorders including Addison's disease and hypoparathyroidism were challenging during neoadjuvant chemoradiotherapy and in the perioperative period.
He made an uneventful recovery after a three-stage oesophagectomy, and histologically, he had a complete pathological response.
To our knowledge, this is the first successful outcome of a patient with APECED and oesophageal carcinoma in the literature.
Squamous cell carcinoma
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy